- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01455766
Volumetric Monitoring in Major Lung Surgery (EVLW-PNEUMO)
September 4, 2012 updated by: Vsevolod V. Kuzkov, Northern State Medical University
Pulmonary Edema Following Major Thoracic Resections: a Value of Perioperative Volumetric Monitoring
The hypothesis of this observational single-center clinical study was to explore the volumetric hemodynamic monitoring in the perioperative period in major and risky thoracic intervention.
The investigators monitored the changes in the volumes of blood in the central vessels and heart chambers as well as a volume of fluid in pulmonary tissue (i.
e. extravascular lung water).
Study Overview
Status
Completed
Conditions
Detailed Description
The goal of this observational study is to investigate into changes in volumetric hemodynamic parameters obtained with a technique of transpulmonary indicator dilution after major thoracic intervention, including pneumonectomy and lobar resections.
The important parameters of hemodynamics were monitored throughout the intervention and 48 hrs postoperatively, including extravascular lung water index, global end-diastolic volume index, etc.
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkhangelsk Region
-
Arkhangelsk, Arkhangelsk Region, Russian Federation, 163000
- Regional Hospital of Arkhangelsk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The study population includes the patients scheduled for extended thoracic resections (lobar resection and pneumonectomy) due to bronchial cancer or severe destructive pulmonary infection (abscess and/or pneumonia).
Description
Inclusion Criteria:
- Informed consent
- Age above 18 and below 80
- Confirmed malignant bronchial neoplasm or
- Destructive pulmonary infection
Exclusion Criteria:
- Pregnant
- Severe pulmonary hypertension
- Pulmonary tuberculosis
- Severe occlusive atherosclerosis of lower extremities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Vsevolod V. Kuzkov, MD, PhD, Northern State Medical University
- Principal Investigator: Mikhail M. Orlov, MD, Regional Hospital of Arkhangelsk
- Study Chair: Mikhail Y. Kirov, MD, PhD, Northern State Medical University
- Study Director: Lars J. Bjertnaes, MD, PhD, University of Trmsoe, Tromsoe, Norway
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2005
Primary Completion (Actual)
February 1, 2008
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
October 17, 2011
First Submitted That Met QC Criteria
October 19, 2011
First Posted (Estimate)
October 20, 2011
Study Record Updates
Last Update Posted (Estimate)
September 5, 2012
Last Update Submitted That Met QC Criteria
September 4, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2005-2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Pulmonary Edema
-
The First Affiliated Hospital of Guangzhou Medical...Not yet recruitingPulmonary Edema - Acute
-
Hospital Raja Permaisuri BainunCompletedAcute Cardiogenic Pulmonary Edema
-
Beijing Chao Yang HospitalCompletedAcute Cardiogenic Pulmonary EdemaChina
-
Assiut UniversityCompletedAcute Cardiogenic Pulmonary EdemaEgypt
-
Fundació Institut de Recerca de l'Hospital de la...Not yet recruitingWeaning Failure | Mechanical Ventilation | Pulmonary Edema - Acute | VExUS | POCUS
-
Beni-Suef UniversityCompletedCardiogenic Pulmonary Edema | Differentiation | Diagnostic Biomarker | Clara Cell Protein | Non-Cardiogenic Pulmonary EdemaEgypt
-
Alberto Dominguez-RodriguezTerminated
-
University Hospital, RouenCompletedSevere Acute Cardiogenic Pulmonary EdemaFrance
-
University Hospital, ToulouseCompleted
-
Institute of Mountain Emergency MedicineCompletedAcute Mountain Sickness | Subclinical High Altitude Pulmonary EdemaItaly